Guidelines for testing, perioperative and bleeding management for dabigatran and rivaroxaban

0 comments

save

feedback

Log in

These guidelines have been produced by PHARMAC in conjunction with bpac^nz, with the assistance of practising specialists. They are provided to assist clinical services to develop their own guidelines in accordance with local procedures and should not be adopted without appropriate review.

Guidelines for testing, perioperative and bleeding management for dabigatran and rivaroxaban

Guidelines for management of bleeding with dabigatran or rivaroxaban: for possible use in local management protocols

View/download guideline

Guidelines for testing and perioperative management of dabigatran and rivaroxaban: for possible use in local management protocols

View/download guideline

Published: 27 July 2018

Made with by the bpac^nz team

CME Activities

Prescribing Reports

Audits

CME Quizzes

Peer Group Discussions

My Bpac account

Guidelines for testing, perioperative and bleeding management for dabigatran and rivaroxaban

Guidelines for management of bleeding with dabigatran or rivaroxaban: for possible use in local management protocols

Guidelines for testing and perioperative management of dabigatran and rivaroxaban: for possible use in local management protocols

Discussion

Add a comment

Partner links